Recce Pharmaceuticals Ltd Sustainability Reports
Recce Pharmaceuticals Ltd is a clinical-stage biotechnology company that develops and commercializes synthetic anti-infectives. Its lead product candidates target antimicrobial-resistant superbugs, sepsis, and various serious bacterial or viral infections.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 549300TKQWXKEHP10T28
FIGI: BBG009XWNPN7
10 reports from 2016 to 2025